Analysts’ September Coverage Rating for Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) is a biotechnology company with a market cap of $857.70 million. The company specialized in the development and commercialization of oncology and hematology drugs. Despite operating through negative earnings currently, Spectrum ... [Read]
Ashford Hospitality Trust, Inc. Allows for Partial Redemption of Series D Preferred Stock
Ashford Hospitality Trust, Inc. (NYSE:$AHT) announced a week ago that the company intends to redeem 379,036 shares of its 8.45% Series D Cumulative Preferred Stock. All shares of this stock will be redeemed in accordance ... [Read]
Intercept Pharmaceuticals Stock Is Falling Today, Here’s Why
As of 10:30 a.m. EDT, shares of Intercept Pharmaceuticals (NASDAQ:$ICPT) declined by 17%. Why? Many speculate the fall was caused by a letter that was sent by Intercept’s Chief Medical Officer to the medical community ... [Read]
Can GoPro Sustain Momentum Post 14% Jump?
After spending most of the year lingering over the single digits, shares of GoPro (NASDAQ:$GPRO) were finally back in the double digits. Last week, the action-camera maker saw its stock jump 14%, after updating its ... [Read]
Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds
A clinical-stage biotech company advancing novel therapies for skin-related diseases, Idera Pharmaceuticals Inc. (NASDAQ:$IDRA) saw its shares surge today. This came after the company presented trial results at the annual European Society for Medical Oncology ... [Read]
FormFactor Outperforms Market, Shares Surge 16.4%
As of today, FormFactor Inc (NASDAQ:$FORM)’s shares have added about 16.4% in the past month, way outperforming the market. Without a doubt, this has to do with the company’s optimal earnings report. Let’s take a ... [Read]
Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report
Plummeting 6.8%, way outperforming the market, Immune Design Corp. (NASDAQ:$IMDZ)’s shares are suffering a serious outlook. Let’s take a look back on Immune Design’s last earnings report. Narrower-than-expected Loss in Q2 The company incurred 2Q17 ... [Read]
Fitbit Enters into Partnership with Glucose Monitor Company Dexcom
Are you interested in the latest computer hardware technology? If so, today might just be your lucky day! On Thursday, September 7, Fitbit, Inc. (NYSE:$FIT) announced that it has entered into partnership with glucose monitor ... [Read]
A Detailed Analysis of Ambarella’s 52-Week Low
Ambarella (NASDAQ:$AMBA) has undeniably faced a tough year; the company’s stock plunged a 40% over year past 12 months, and it’s now hovering near a 52-week low. Despite those gloomy statistics, investors are looking at ... [Read]
Here’s Why GoPro Shares Are Soaring Today
GoPro Inc (NASDAQ:$GPRO) is an iconic action camera maker, and the company’s shares soared a whopping 17% as of Thursday morning trading. While the company has seen a long-held loyalty in consumers based on its ... [Read]